Who will benefit from psychedelic medicine?
The troubles of accessibility are already present. MDMA-assisted psychotherapy is a turning point in the mainstreaming of psychedelics. These substances are being touted as a game-changing intervention for mental health. But it’s not clear if their promise will be accessible to all. Whitney Joiner investigates.
From The Washington Post